Declining rural oncologist supply in the United States: a workforce analysis from 2014 to 2025
The Oncologist · 2026
DOI: 10.1093/oncolo/oyag333 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von David X Zheng. Beteiligte Einrichtung: Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Rural Health Services, Oncologists, Health Workforce, Medical Oncology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Purpose
Rural Americans experience higher cancer incidence and mortality than their urban counterparts, yet oncology physician supply to rural areas is incompletely characterized. We determined longitudinal trends in the proportion of oncologists practicing rurally and identified characteristics associated with rural practice.
Methods
Physicians reporting a primary specialty of hematology, hematology/oncology, or medical oncology were identified from annual archived versions of the CMS Physician Compare Database (2014-2025). Rural status was determined from Rural-Urban Commuting Area codes applied to practice ZIP code (codes 4-10 = rural). Temporal trends were assessed with Mann-Kendall tests. Rural and urban physician characteristics were compared using chi-squared tests and multivariable logistic regression.
Results
We identified 19,807 unique oncologists (14,272 in 2025). Despite a 26% workforce expansion, the rural proportion declined from 11.1% to 8.0% (τ = −0.73, P = .001). Per capita, rural supply fell from 6.5 to 5.5 per 100,000 adults aged ≥55 (τ = −0.58, P = .009) while urban supply rose from 11.7 to 13.1 (τ = +0.48), widening the urban-to-rural ratio from 1.8 to 2.4. Rural oncologists were more likely to be male, late career, and in mid-size groups (all P < .001). Academic medical center affiliation (aOR 0.10) and large group size (aOR 0.40) were associated with decreased odds of rural practice, whereas late career stage (aOR 1.58) and Midwest region (aOR 1.62) were associated with increased odds.
Conclusions
The rural oncology workforce is declining proportionally and per capita despite overall growth. Retirement of late-career rural oncologists without early-career replacement threatens to further erode rural cancer care access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
- Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States.
ORCID-Profile: David X Zheng
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zheng, D. X. (2026). Declining rural oncologist supply in the United States: a workforce analysis from 2014 to 2025. The Oncologist. https://doi.org/10.1093/oncolo/oyag333
Vancouver
Zheng DX. Declining rural oncologist supply in the United States: a workforce analysis from 2014 to 2025. The Oncologist. 2026. doi:10.1093/oncolo/oyag333
BibTeX
@article{Zheng2026,
author = {Zheng, David X},
title = {Declining rural oncologist supply in the United States: a workforce analysis from 2014 to 2025},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyag333}
}
EUVIMED